Doctors track youngest patients on muscle drug
NCT ID NCT07154654
Summary
This study is a long-term patient registry that will observe and collect information from children under 6 years old who have a myotonic disorder and are already being treated with the drug mexiletine. The main goal is to understand the long-term safety of this medication in very young children and to see how doctors are using it in practice. It will follow these children for at least two years during their routine medical care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYOTONIC DISORDERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre Hospitalier Universitaire de Clermont-Ferrand
RECRUITINGClermont-Ferrand, France
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.